Linagliptin Metabolite CD1790 - Request Quote
Linagliptin Metabolite CD1790
| SZ CAT No: | SZ-L024019 |
| CAS No | NA |
| Mol.F. | C25H27N7O3 |
| Mol.Wt. | 473.5 |
| Inv. Status | Synthesis on demand |
Chemical Name :
Shipping Temperature :
HSN Code :
Country of Origin :
Smiles :
Usage Note:
Linagliptin Metabolite CD1790 is chemically (R)-7-(but-2-yn-1-yl)-8-(3-hydroxypiperidin-1-yl)-3-methyl-1-((4-methylquinazolin-2-yl)methyl)-3,7-dihydro-1H-purine-2,6-dione. Linagliptin Metabolite CD1790 is supplied with detailed characterization data compliant with regulatory guideline. Linagliptin Metabolite CD1790 can be used for the analytical method development, method validation (AMV), Quality Controlled (QC) application for Abbreviated New Drug Application (ANDA) or during commercial production of Linagliptin.
The product can be used as reference standards and further traceability against pharmacopeial standards (USP or EP) can be provided based on feasibility. SynZeal products are for analytical purpose only and not for human use.
Applications & Regulatory Use Cases
buy high quality Linagliptin Metabolite CD1790
Purchase Linagliptin Metabolite CD1790
Linagliptin Metabolite CD1790 suppliers
Linagliptin Metabolite CD1790 manufacturers
Linagliptin Metabolite CD1790 price
Order Linagliptin Metabolite CD1790
Enquire Linagliptin Metabolite CD1790
Linagliptin Metabolite CD1790 cost
Linagliptin Metabolite CD1790 Supplier
Linagliptin Metabolite CD1790 Distributor
Linagliptin Metabolite CD1790 for Method Validation
Linagliptin Reference Standard
Linagliptin Metabolite CD1790 for ANDA Filing
Linagliptin Metabolite CD1790 for Forced Degradation Studies
Linagliptin Metabolite CD1790 Identification Standards
Linagliptin Metabolite CD1790 for DMF Filing
Related Products
Disclaimer
SynZeal product information given on this website is as per the existing understanding while publishing the details on website. The customer is responsible for assessing the accuracy of the information at the time of actual purchase.
SynZeal will update these details as per new developments or findings in product specifications without further notice.